Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Staar Surgical Co. | 13 | 1 | 1 | 0 | €29.30 | €47.59 | 62.435% |
| Adverum Biotechnologies Inc. | 11 | 0 | 2 | 0 | €1.38 | €23.35 | 1591.667% |
| ProQR Therapeutics N.V. | 7 | 2 | 0 | 0 | €1.85 | €2.32 | 25.720% |
| R1 RCM Inc. | 23 | 0 | 0 | 0 | €12.60 | €17.21 | 36.608% |
| Biolife Solutions Inc | 1 | 0 | 0 | 0 | €23.20 | - | - |
| iRhythm Technologies Inc | 15 | 0 | 5 | 0 | €61.50 | €114.25 | 85.766% |
| Pro-Dex Inc. | 10 | 0 | 0 | 0 | €19.20 | - | - |
| Purple Biotech Ltd. ADR | 7 | 0 | 1 | 0 | €0.38 | €9.21 | 2322.895% |
| Rhythm Pharmaceuticals | 15 | 0 | 1 | 0 | €44.80 | €46.51 | 3.806% |
| Motus GI Holdings Inc. | 1 | 0 | 0 | 0 | €0.43 | €2.37 | 452.929% |
| Nektar Therapeutics | 4 | 1 | 0 | 0 | €1.15 | €2.40 | 107.972% |
| Merck & Co. Inc. | 33 | 1 | 5 | 0 | €107.20 | €125.91 | 17.451% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 2 | 0 | €18.32 | €26.64 | 45.451% |
| Drägerwerk AG & Co. KGaA ST | 3 | 0 | 0 | 0 | €44.50 | €66.00 | 48.315% |
| EssilorLuxottica SA | 3 | 0 | 1 | 0 | €214.40 | €260.00 | 21.269% |
| Novo Nordisk A/S | 6 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Trinity Biotech ADR | 26 | 0 | 2 | 0 | €0.41 | - | - |
| Immutep LTD ADR | 2 | 0 | 1 | 0 | €2.38 | €4.00 | 68.067% |
| Verastem Inc. | 15 | 0 | 4 | 0 | €2.26 | €16.16 | 615.102% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €2.53 | €4.62 | 82.668% |
| Abbott Laboratories | 20 | 0 | 2 | 0 | €102.48 | €116.25 | 13.434% |
| UCB S.A. | 1 | 0 | 0 | 0 | €164.35 | - | - |
| Cigna Corp. | 24 | 0 | 4 | 0 | €327.20 | €360.98 | 10.324% |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | €26.31 | €35.01 | 33.049% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 7 | 0 | €448.50 | €450.36 | 0.416% |